These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 2953224)
21. Effects of the new angiotensin-converting enzyme inhibitor, ramipril, in patients with essential hypertension. Stumpe KO; Overlack A; Kolloch R; Schatz J; Witte PU; Pahnke K Klin Wochenschr; 1986 Jun; 64(12):558-62. PubMed ID: 3016405 [TBL] [Abstract][Full Text] [Related]
22. [Acute effects of the angiotensin converting enzyme inhibitor ramipril in patients with coronary heart disease]. Unterberg C; Buchwald A; Vogt A; Wiegand V Med Klin (Munich); 1990 Feb; 85(2):78-81. PubMed ID: 2138704 [TBL] [Abstract][Full Text] [Related]
23. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril. Turini GA; Waeber B; Brunner HR Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835 [TBL] [Abstract][Full Text] [Related]
24. Peripheral hemodynamic effects of captopril in patients with congestive heart failure. Nishimura H; Kubo S; Ueyama M; Kubota J; Kawamura K Am Heart J; 1989 Jan; 117(1):100-5. PubMed ID: 2643280 [TBL] [Abstract][Full Text] [Related]
25. Differential long-term intrarenal and neurohormonal effects of captopril and prazosin in patients with chronic congestive heart failure: importance of initial plasma renin activity. Mettauer B; Rouleau JL; Bichet D; Kortas C; Manzini C; Tremblay G; Chatterjee K Circulation; 1986 Mar; 73(3):492-502. PubMed ID: 3512121 [TBL] [Abstract][Full Text] [Related]
26. Acute renal effects of captopril in patients with congestive heart failure. Ribstein J; Mimran A J Clin Hypertens; 1986 Sep; 2(3):238-44. PubMed ID: 3023554 [TBL] [Abstract][Full Text] [Related]
27. Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats. Moursi MG; Ganten D; Lang RE; Unger T J Hypertens Suppl; 1986 Oct; 4(3):S495-8. PubMed ID: 3023591 [TBL] [Abstract][Full Text] [Related]
28. Angiotensin-converting enzyme inhibition in congestive heart failure: the concept. Cohn JN; Levine TB Am J Cardiol; 1982 Apr; 49(6):1480-3. PubMed ID: 6176108 [TBL] [Abstract][Full Text] [Related]
29. Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone. Wenting GJ; Man in't veld AJ; Woittiez AJ; Boomsma F; Laird-Meeter K; Simoons ML; Hugenholtz PG; Schalekamp MA Br Heart J; 1983 Jan; 49(1):65-76. PubMed ID: 6336940 [TBL] [Abstract][Full Text] [Related]
30. [Comparison of captopril with enalapril in the therapy of heart failure: effect on hemodynamics and kidney function]. Osterziel KJ; Dietz R; Mikulaschek K; Röhrig N; Schmid W; Manthey J; Kübler W Z Kardiol; 1988 Jun; 77(6):378-84. PubMed ID: 2850682 [TBL] [Abstract][Full Text] [Related]
31. Blood pressure response of nephrectomized subjects and patients with essential hypertension to ramipril: indirect evidence that inhibition of tissue angiotensin converting enzyme is important. Wenting GJ; Blankestijn PJ; Poldermans D; van Geelen J; Derkx FH; Man in't Veld AJ; Schalekamp MA Am J Cardiol; 1987 Apr; 59(10):92D-97D. PubMed ID: 3034041 [TBL] [Abstract][Full Text] [Related]
32. The renin-angiotensin system and ramipril, a new converting enzyme inhibitor. Vasmant D; Bender N J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S46-52. PubMed ID: 2483429 [TBL] [Abstract][Full Text] [Related]
33. Neurohumoral and hemodynamic changes in congestive heart failure: lack of correlation and evidence of compensatory mechanisms. Rouleau JL; Kortas C; Bichet D; de Champlain J Am Heart J; 1988 Sep; 116(3):746-57. PubMed ID: 2970771 [TBL] [Abstract][Full Text] [Related]
34. Long-term control of congestive heart failure with captopril. Fouad FM; Tarazi RC; Bravo EL; Hart NJ; Castle LW; Salcedo EE Am J Cardiol; 1982 Apr; 49(6):1489-96. PubMed ID: 6803563 [TBL] [Abstract][Full Text] [Related]
35. Therapeutic efficacy and tolerance of ramipril in hypertensive patients with renal failure. Kindler J; Schunkert H; Gassmann M; Lahn W; Irmisch R; Debusmann ER; Ocón-Pujadas J; Ritz E; Sieberth HG J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S55-8. PubMed ID: 2474105 [TBL] [Abstract][Full Text] [Related]
36. Sublingual administration of captopril versus nitroglycerin in patients with severe congestive heart failure. Haude M; Steffen W; Erbel R; Meyer J Int J Cardiol; 1990 Jun; 27(3):351-9. PubMed ID: 2112516 [TBL] [Abstract][Full Text] [Related]
37. Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure. Pacher R; Stanek B; Globits S; Berger R; Hülsmann M; Wutte M; Frey B; Schuller M; Hartter E; Ogris E Eur Heart J; 1996 Aug; 17(8):1223-32. PubMed ID: 8869864 [TBL] [Abstract][Full Text] [Related]
38. Ramipril for hypertension secondary to renal artery stenosis. Changes in blood pressure, the renin-angiotensin system and total and divided renal function. Tillman DM; Adams FG; Gillen G; Morton JJ; Robertson JI Am J Cardiol; 1987 Apr; 59(10):133D-142D. PubMed ID: 3034022 [TBL] [Abstract][Full Text] [Related]
39. [The effect of bunazosin vs captopril on hemodynamic and neurohumoral parameters in patients with congestive heart failure]. Kawahara Y; Hasegawa K; Sawayama T; Inoue S; Nakamura T; Kakumae S; Tadaoka S; Nakao M; Nezuo S Kokyu To Junkan; 1989 Dec; 37(12):1333-40. PubMed ID: 2575781 [TBL] [Abstract][Full Text] [Related]
40. Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure. Ricci S; Zaniol P; Teglio V; Baraldi P; Mattioli G Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):209S-215S. PubMed ID: 6291564 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]